Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs

Clinical Rheumatology

Volumn 30, Issue 12, 2011, Pages 1555-1561

  Kapetanovic, Meliha Crnkic ^a   Roseman, Carmen ^a   Jönsson, Göran ^b   Truedsson, Lennart ^c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

23 Valent pneumococcal polysaccharide vaccine; 7 Valent pneumococcal conjugate vaccine; Antibody response; Pneumococcal vaccination; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 82655181787     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1856-5     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices 2010 Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23) MMWR Morb Mortal Wkly Rep 59 34 1102 1106
2. Recommendations of the Swedish National Board of Health and Welfare. Pneumococcal Vaccination(1994). (Socialstyrelsens allmänna råd) SOSFS 1994:26. Vaccination mot pneumokocker. Available at http://www.socialstyrelsen. se/sosfs/1994-26
3. Y Vinogradova J Hippisley-Cox C Coupland 2009 Identification of new risk factors for pneumonia: population-based case-control study Br J Gen Pract 59 567 e329 e338 19843413 10.3399/bjgp09X472629
4. JD Greenberg G Reed JM Kremer E Tindall A Kavanaugh C Zheng W Bishai MC Hochberg CORRONA Investigators 2010 Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry Ann Rheum Dis 69 2 380 386 19359261 10.1136/ard.2008.089276 1:CAS:528:DC%2BC3cXitlKrtrg%3D Epub 2009 Apr 8
5. SA Moberley J Holden DP Tatham RM Andrews 2008 Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst Rev 23 1 CD000422
6. A Huss P Scott AE Stuck C Trotter M Egger 2009 Efficacy of pneumococcal vaccination in adults: a meta-analysis CMAJ 180 1 48 58 19124790 10.1503/cmaj.080734
7. DM Musher SB Manof C Liss RD McFetridge RD Marchese B Bushnell F Alvarez C Painter MD Blum JL Silber 2010 Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults J Infect Dis 201 4 516 524 20092407 10.1086/649839 1:CAS:528:DC%2BC3cXjtFGjtrw%3D
8. U Sankilampi R Isoaho A Bloigu SL Kivelä M Leinonen 1997 Effect of age, sex and smoking habits on pneumococcal antibody levels in an elderly population Int J Epidemiol 26 2 420 427 9169180 10.1093/ije/26.2.420 1:STN:280:DyaK2szht1Oguw%3D%3D (Pubitemid 27190316)
9. MC Kapetanovic T Saxne A Sjöholm L Truedsson G Jönsson P Geborek 2006 Influence of methotrexate, TNF-blocker and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatology 45 106 111 16287919 10.1093/rheumatology/kei193 1:CAS:528:DC%2BD2MXhtlagtbjP (Pubitemid 43033885)
10. Prevenar. Information från Läkemedelsverket (Medical Products Agency, Sweden) 2001;12(4). ISSN 1101-7104. Available at http://www. lakemedelsverket.se
11. CDC 2005 Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive disease-United States, 1998-2003 MMWR Morb Mortal Wkly Rep 54 36 893 897
12. CA Lexau R Lynfield R Danila T Pilishvili R Facklam MM Farley LH Harrison W Schaffner A Reingold NM Bennett J Hadler PR Cieslak CG Whitney Active Bacterial Core Surveillance Team 2005 Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine JAMA 294 16 2043 2051 16249418 10.1001/jama.294.16.2043 1:CAS:528:DC%2BD2MXhtFKhu7fL (Pubitemid 41539937)
13. Kapetanovic MC, Roseman C, Saxne T, Jönsson G, Truedsson L, Geborek P (2011) Methotrexate but not TNF-blockers reduces immune response following pneumococcal vaccination using 7-valent conjugate pneumococcal vaccine (Prevenar®) in adult patients with established arthritis. Arthritis Rheum (in press)
14. WHO. Training manual for Streptococcus pneumoniae serotype specific IgG (PN PS ELISA). Available at: http://www.vaccine.uab.edu/ELISA%20Protocol.pdf. Accessed 30 Sept 2010
15. GD Rodenburg SC de Greeff AG Jansen HE de Melker LM Schouls E Hak L Spanjaard EA Sanders A van der Ende 2010 Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands Emerg Infect Dis 16 5 816 823 20409372
16. CG Whitney T Pilishvili MM Farley W Schaffner AS Craig R Lynfield AC Nyquist KA Gershman M Vazquez NM Bennett A Reingold A Thomas MP Glode ER Zell JH Jorgensen B Beall A Schuchat 2006 Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study Lancet 368 9546 1495 1502 17071283 10.1016/S0140-6736(06)69637-2 1:CAS:528:DC%2BD28XhtFent7jM (Pubitemid 44634693)
17. D Foster AS Walker J Paul D Griffiths K Knox TE Peto DW Crook Oxford Invasive Pneumococcal Surveillance Group 2011 Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England J Med Microbiol 60 Pt 1 91 97 20864548 10.1099/jmm.0.023135-0 Epub 2010 Sep 23
18. I Ridda CR Macintyre R Lindley Z Gao JS Sullivan FF Yuan PB McIntyre 2009 Immunological responses to pneumococcal vaccine in frail older people Vaccine 27 10 1628 1636 19100304 10.1016/j.vaccine.2008.11.098 1:CAS:528: DC%2BD1MXit1ajtbg%3D Epub 2008 Dec 17
19. MA Shelly H Jacoby GJ Riley BT Graves M Pichichero JJ Treanor 1997 Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults Infect Immun 65 1 242 247 8975918 1:CAS:528:DyaK2sXhvVyrsg%3D%3D (Pubitemid 27010311)
20. A de Roux B Schmöle-Thoma GR Siber JG Hackell A Kuhnke N Ahlers SA Baker A Razmpour EA Emini PD Fernsten WC Gruber S Lockhart O Burkhardt T Welte HM Lode 2008 Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory Clin Infect Dis 46 7 1015 1023 18444818 10.1086/529142 (Pubitemid 351589866)
21. MT Dransfield MH Nahm MK Han S Harnden GJ Criner FJ Martinez PD Scanlon PG Woodruff GR Washko JE Connett NR Anthonisen WC Bailey COPD Clinical Research Network 2009 Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease Am J Respir Crit Care Med 180 6 499 505 19556517 10.1164/rccm.200903-0488OC 1:CAS:528:DC%2BD1MXhtlSjtb%2FP Epub 2009 Jun
22. AP Wessels Cope M Londei NR Chu SB Cohen MJ Elliott FM Brennan RN Maini M Feldmann 1994 Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis J Clin Invest 94 2 749 760 10.1172/JCI117394
23. JA Wessels TW Huizinga HJ Guchelaar 2008 Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis Rheumatology (Oxford) 47 3 249 255 10.1093/rheumatology/kem279 1:CAS:528:DC%2BD1cXitlKktbY%3D Epub 2007 Nov 28 (Pubitemid 351267187)
24. J Ongrádi V Kövesdi 2010 Factors that may impact on immunosenescence: an appraisal Immun Ageing 7 7 20546588 10.1186/1742-4933-7-7
25. S Visvanathan GF Keenan DG Baker AI Levinson CL Wagner 2007 Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone J Rheumatol 34 5 952 957 17444589 1:CAS:528:DC%2BD2sXmtV2rt7Y%3D (Pubitemid 46774837)
26. ZB Harboe TL Benfield P Valentiner-Branth T Hjuler L Lambertsen M Kaltoft K Krogfelt HC Slotved JJ Christensen HB Konradsen 2010 Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades Clin Infect Dis 50 3 329 337 20047478 10.1086/649872